Open Access

Perspectives on the results of recent clinical outcome trials with icosapent ethyl

Topic: Lipid-Lowering Agents
Sponsored by PACE-CME – Supported by an unrestricted educational grant from Amarin

Congress Presentation

About the speaker

Professor Philippe Gabriel Steg

Hospital Bichat-Claude Bernard, Paris (France)
65 presentations
10 followers

4 more presentations in this session

Introduction

Speaker: Professor P. Libby (Boston, US)

Thumbnail

Challenges in atherosclerotic cardiovascular disease reduction and triglyceride-related risk

Speaker: Professor E. Stroes (Amsterdam, NL)

Thumbnail

Integrating icosapent ethyl in cardiovascular risk reduction strategies: practical guidance

Speaker: Doctor P. Taub (La Jolla, US)

Thumbnail

Discussion

Speaker: Professor P. Libby (Boston, US) Professor E. Stroes (Amsterdam, NL) Professor P. Steg (Paris, FR) Doctor P. Taub (La Jolla, US)

Thumbnail

Access the full session

Improving the management of patients with atherosclerotic cardiovascular disease: the evolving role of icosapent ethyl

Speakers: Professor P. Steg, Professor P. Libby, Professor E. Stroes, Doctor P. Taub, Professor P. Libby...
Thumbnail

About the event

Image

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

ESC 365 is supported by